APOE4 and age affect the brain entorhinal cortex structure and blood arachidonic acid and docosahexaenoic acid levels after mild TBI
G Aldrich, JE Evans, R Davis, L Jurin, S Oberlin… - Scientific Reports, 2024 - nature.com
A reduction in the thickness and volume of the brain entorhinal cortex (EC), together with
changes in blood arachidonic acid (AA) and docosahexaenoic acid (DHA), are associated …
changes in blood arachidonic acid (AA) and docosahexaenoic acid (DHA), are associated …
Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype
Proteome changes associated with APOE4 variant carriage that are independent of
Alzheimer's disease (AD) pathology and diagnosis are unknown. This study investigated …
Alzheimer's disease (AD) pathology and diagnosis are unknown. This study investigated …
Cerebrospinal fluid proteome profiling using machine learning shows a unique protein signature associated with APOE4 genotype
APOE4 is the biggest genetic risk factor for Alzheimers disease (AD). Proteome-wide
changes independent of AD brain pathology and whether these extend to APOE4 carriers …
changes independent of AD brain pathology and whether these extend to APOE4 carriers …
APOE 𝜀4‐related blood–brain barrier breakdown is associated with microstructural abnormalities
INTRODUCTION Blood–brain barrier (BBB) dysfunction occurs in Alzheimer's disease (AD).
Yet, the stage at which it appears along the AD time course and whether it contributes to …
Yet, the stage at which it appears along the AD time course and whether it contributes to …
APOE
IntroductionBlood-brain barrier (BBB) dysfunction occurs in Alzheimer's disease (AD). Yet,
the stage at which it appears along the AD time course and whether it contributes to …
the stage at which it appears along the AD time course and whether it contributes to …